O'Byrne Jason bought OLMA
September 1, 2026 · Form 4 insider transaction
O'Byrne Jason bought 650,000 shares of Olema Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
650,000
Price
$0.00
Total value
N/A
InsiderO'Byrne Jason
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 1, 2026
Filing dateSeptember 2, 2026
Shares owned after650,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option vest on August 11, 2027 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.